Oncolytic viruses offer new hope to millions of patients with incurable cancer. One promising class of oncolytic viruses is Measles virus, but its broad administration to cancer patients is currently hampered by the inability to produce the large amounts of virus needed for treatment (1010–1012 virus particles per dose). Measles virus is unstable, leading to very low virus titers during production. The time of infection and time of harvest are therefore critical parameters in a Measles virus production process, and their optimization requires an accurate online monitoring system. We integrated a probe based on dielectric spectroscopy (DS) into a stirred tank reactor to characterize the Measles virus production process in adherent growing Ve...
Oncolytic measles virus (MV) is a promising treatment for cancer but titers of up to 1011 infectious...
Cancer is one of the leading causes of death worldwide, and cancers which metastasise, the process o...
This study proposes an easy to use in situ device, based on multi-frequency permittivity measurement...
International audienceOver the last decade industrial manufacturing of viral vaccines and viral vect...
International audienceOver the last decade industrial manufacturing of viral vaccines and viral vect...
International audienceOver the last decade industrial manufacturing of viral vaccines and viral vect...
International audienceOver the last decade industrial manufacturing of viral vaccines and viral vect...
Measles virus (MV) with attenuated pathogenicity has potential as oncolytic agent. However, the clin...
Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinic...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
There is an increased interest from the vaccine industry to use mammalian cell cultures for influenz...
Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinic...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied...
Oncolytic measles virus (MV) is a promising treatment for cancer but titers of up to 1011 infectious...
Cancer is one of the leading causes of death worldwide, and cancers which metastasise, the process o...
This study proposes an easy to use in situ device, based on multi-frequency permittivity measurement...
International audienceOver the last decade industrial manufacturing of viral vaccines and viral vect...
International audienceOver the last decade industrial manufacturing of viral vaccines and viral vect...
International audienceOver the last decade industrial manufacturing of viral vaccines and viral vect...
International audienceOver the last decade industrial manufacturing of viral vaccines and viral vect...
Measles virus (MV) with attenuated pathogenicity has potential as oncolytic agent. However, the clin...
Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinic...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
There is an increased interest from the vaccine industry to use mammalian cell cultures for influenz...
Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinic...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied...
Oncolytic measles virus (MV) is a promising treatment for cancer but titers of up to 1011 infectious...
Cancer is one of the leading causes of death worldwide, and cancers which metastasise, the process o...
This study proposes an easy to use in situ device, based on multi-frequency permittivity measurement...